A detailed history of Raymond James & Associates transactions in Aptargroup, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 83,520 shares of ATR stock, worth $14.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
83,520
Previous 94,352 11.48%
Holding current value
$14.4 Million
Previous $13.3 Million 0.65%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$138.54 - $160.11 $1.5 Million - $1.73 Million
-10,832 Reduced 11.48%
83,520 $13.4 Million
Q2 2024

Jul 19, 2024

BUY
$137.2 - $150.79 $5.41 Million - $5.95 Million
39,426 Added 71.78%
94,352 $13.3 Million
Q1 2024

Apr 22, 2024

BUY
$122.88 - $144.66 $235,560 - $277,313
1,917 Added 3.62%
54,926 $7.9 Million
Q4 2023

Jan 16, 2024

BUY
$121.17 - $128.59 $30,534 - $32,404
252 Added 0.48%
53,009 $6.55 Million
Q3 2023

Oct 24, 2023

SELL
$112.47 - $132.89 $3.61 Million - $4.27 Million
-32,096 Reduced 37.83%
52,757 $6.6 Million
Q2 2023

Jul 25, 2023

SELL
$112.49 - $121.7 $6.94 Million - $7.51 Million
-61,716 Reduced 42.11%
84,853 $9.83 Million
Q1 2023

Apr 14, 2023

SELL
$109.21 - $120.25 $54,386 - $59,884
-498 Reduced 0.34%
146,569 $17.3 Million
Q4 2022

Feb 08, 2023

BUY
$93.98 - $110.93 $1.2 Million - $1.41 Million
12,750 Added 9.49%
147,067 $16.2 Million
Q3 2022

Oct 25, 2022

BUY
$95.03 - $112.07 $1.12 Million - $1.32 Million
11,766 Added 9.6%
134,317 $12.8 Million
Q2 2022

Aug 12, 2022

SELL
$94.77 - $121.41 $17.5 Million - $22.4 Million
-184,137 Reduced 60.04%
122,551 $12.6 Million
Q1 2022

May 11, 2022

SELL
$110.19 - $123.68 $2.19 Million - $2.46 Million
-19,892 Reduced 6.09%
306,688 $36 Million
Q4 2021

Feb 08, 2022

SELL
$113.67 - $134.45 $221,542 - $262,043
-1,949 Reduced 0.59%
326,580 $40 Million
Q3 2021

Nov 02, 2021

BUY
$119.35 - $141.18 $2.1 Million - $2.49 Million
17,605 Added 5.66%
328,529 $39.2 Million
Q2 2021

Aug 11, 2021

BUY
$140.1 - $157.56 $535,322 - $602,036
3,821 Added 1.24%
310,924 $43.8 Million
Q1 2021

May 14, 2021

BUY
$128.28 - $144.82 $3.47 Million - $3.91 Million
27,029 Added 9.65%
307,103 $43.5 Million
Q4 2020

Feb 12, 2021

BUY
$112.34 - $136.89 $2.46 Million - $2.99 Million
21,867 Added 8.47%
280,074 $38.3 Million
Q3 2020

Nov 04, 2020

BUY
$112.1 - $122.26 $2.25 Million - $2.45 Million
20,060 Added 8.42%
258,207 $29.2 Million
Q2 2020

Jul 28, 2020

BUY
$94.19 - $113.58 $16 Million - $19.2 Million
169,383 Added 246.33%
238,147 $26.7 Million
Q1 2020

Apr 21, 2020

BUY
$83.93 - $118.22 $352,841 - $496,996
4,204 Added 6.51%
68,764 $6.85 Million
Q4 2019

Feb 12, 2020

BUY
$108.22 - $119.25 $336,023 - $370,271
3,105 Added 5.05%
64,560 $7.47 Million
Q3 2019

Nov 07, 2019

BUY
$116.48 - $125.92 $170,759 - $184,598
1,466 Added 2.44%
61,455 $7.28 Million
Q2 2019

Aug 06, 2019

SELL
$107.22 - $124.34 $780,025 - $904,573
-7,275 Reduced 10.82%
59,989 $7.46 Million
Q1 2019

May 06, 2019

BUY
$89.09 - $106.39 $373,376 - $445,880
4,191 Added 6.64%
67,264 $7.16 Million
Q4 2018

Feb 11, 2019

SELL
$89.7 - $108.15 $1.82 Million - $2.19 Million
-20,262 Reduced 24.31%
63,073 $5.93 Million
Q3 2018

Nov 14, 2018

BUY
$93.29 - $111.97 $220,630 - $264,809
2,365 Added 2.92%
83,335 $8.98 Million
Q2 2018

Aug 14, 2018

BUY
$87.93 - $96.13 $201,535 - $220,329
2,292 Added 2.91%
80,970 $7.56 Million
Q1 2018

May 14, 2018

BUY
$81.38 - $91.83 $41,259 - $46,557
507 Added 0.65%
78,678 $7.07 Million
Q4 2017

Feb 14, 2018

BUY
$84.76 - $89.2 $117,392 - $123,542
1,385 Added 1.8%
78,171 $6.75 Million
Q3 2017

Nov 13, 2017

BUY
$80.93 - $87.08 $214,707 - $231,023
2,653 Added 3.58%
76,786 $6.63 Million
Q2 2017

Aug 14, 2017

BUY
N/A
74,133
74,133 $6.44 Million

Others Institutions Holding ATR

About APTARGROUP, INC.


  • Ticker ATR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 65,337,000
  • Market Cap $11.2B
  • Description
  • AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps...
More about ATR
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.